The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Novartis; Pfizer; Regeneron; Roche; Sanofi; Takeda
Research Funding - Celgene/Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Abbvie; Adaptive Biotechnologies; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Novartis; Pfizer; Regeneron; Roche; Sanofi; Takeda
Validation of prototype biomarkers to identify risk factors of inflammatory adverse events (iAEs) following idecabtagene vicleucel (ide-cel) infusion in patients with relapsed and refractory multiple myeloma (RRMM) in KarMMa-3.
 
Sanhita Sengupta
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Clara Amorosi
Employment - Bristol-Myers Squibb
 
Mandeep Takhar
Employment - Bristol-Myers Squibb
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
 
Salomon Manier
No Relationships to Disclose
 
Rachid C. Baz
Honoraria - Hikma Pharmaceuticals
Consulting or Advisory Role - BMS; Janssen; Pfizer; Sanofi
Research Funding - Abbvie (Inst); Arvinas (I); BMS (Inst); Daiichi Sankyo/Lilly (I); Janssen (Inst); Karyopharm Therapeutics (Inst); Marker Therapeutics (I); Pionyr (I); Quantum Leap Healthcare Collaborative (I); Regeneron (I); Seagen (I); Zymeworks (I)
Other Relationship - GlaxoSmithKline
 
Krishna Rangadhamarao Juluri
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Moderna Therapeutics
 
Allison Kaeding
No Relationships to Disclose
 
Afshin Mashadi-Hossein
Employment - Bristol-Myers Squibb; Umoja Biopharma
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Julia Piasecki
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Amgen; Cascadian Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Timothy Brandon Campbell
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Shari Kaiser
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Julie Rytlewski
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Adaptive Biotechnologies; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Md Shamsuzzaman
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Nathan Martin
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb